Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -243,360 | -178,756 | -120,944 | -54,074 | -180,307 |
| Depreciation Amortization | 8,223 | 5,377 | 2,672 | 919 | 962 |
| Accounts payable and accrued liabilities | 6,984 | 10 | -727 | 1,609 | -1,399 |
| Other Working Capital | -244 | -8,842 | -10,403 | -9,584 | 12,228 |
| Other Operating Activity | 52,037 | 42,587 | 34,708 | 8,835 | 23,682 |
| Operating Cash Flow | $-176,360 | $-139,624 | $-94,694 | $-52,295 | $-144,834 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 240,225 | 173,575 | 153,042 | 31,356 | -140,578 |
| PPE Investments | -1,503 | -1,253 | -954 | -513 | -2,966 |
| Other Investing Activity | -23,380 | -18,080 | -17,805 | -2,805 | -3,600 |
| Investing Cash Flow | $215,342 | $154,242 | $134,283 | $28,038 | $-147,144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 193,596 | 193,596 | 193,596 | N/A | 28,222 |
| Common Stock Issued | 118,944 | 118,695 | 117,804 | 571 | 293,356 |
| Financing Cash Flow | $312,540 | $312,291 | $311,400 | $571 | $321,578 |
| Exchange Rate Effect | 9 | -42 | -16 | -50 | 70 |
| Beginning Cash Position | 135,089 | 135,089 | 135,089 | 135,089 | 105,419 |
| End Cash Position | 486,620 | 461,956 | 486,062 | 111,353 | 135,089 |
| Net Cash Flow | $351,531 | $326,867 | $350,973 | $-23,736 | $29,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -176,360 | -139,624 | -94,694 | -52,295 | -144,834 |
| Capital Expenditure | -1,503 | -1,253 | -954 | -513 | -2,966 |
| Free Cash Flow | -177,863 | -140,877 | -95,648 | -52,808 | -147,800 |